by University of Reading Credit: Pixabay/CC0 Public DomainA form of computerized attention and memory training can improve impaired attention and memory issues in women treated for breast cancer, University of Reading researchers have found. “Chemo-brain” refers to cognitive problems like forgetfulness, difficulty concentrating, and lapses in everyday attention, which are common side effects of breast cancer...
Immune cells that keep the brain free of debris but also contribute to inflammation are the likely culprits behind the concentration and memory problems that sometimes follow one type of chemotherapy, a new study in mice suggests. Researchers previously showed that female mice given paclitaxel, a drug commonly used to treat breast, ovarian and other cancers, developed memory problems...
by Saint Louis University Graphical abstract. Credit: Journal of Clinical Investigation (2022). DOI: 10.1172/JCI157738 Though chemotherapy can be lifesaving, the cancer treatment often leaves patients suffering from debilitating side effects, including cognitive impairments in processing speed, memory, executive function and attention. Dubbed “chemo brain,” these lingering symptoms can dramatically impact patients’ quality of life long after they...
By Elizabeth Cooney Jan. 28, 2022 Stanford neuro-oncologist Michelle Monje is studying the link between “chemo brain” and long Covid’s brain fog. Back in the pandemic’s first wave, Michelle Monje was worried about Covid-19’s power to muddle the brain. Seeing the massive inflammatory response to the virus and early signs of what became known as...
By Elizabeth Cooney Jan. 28, 2022 Stanford neuro-oncologist Michelle Monje is studying the link between “chemo brain” and long Covid’s brain fog. STANFORD Back in the pandemic’s first wave, Michelle Monje was worried about Covid-19’s power to muddle the brain. Seeing the massive inflammatory response to the virus and early signs of what became known...
More than half of cancer survivors suffer from cognitive impairment from chemotherapy that lingers for months or years after the cancer is gone. In a new study explaining the cellular mechanisms behind this condition, scientists at the Stanford University School of Medicine have demonstrated that a widely used chemotherapy drug, methotrexate, causes a complex set...
